Literature DB >> 29417161

Comment on "Hysteropreservation versus hysterectomy in the surgical treatment of uterine prolapse: systematic review and meta-analysis".

Renée J Detollenaere1, Hugo W F van Eijndhoven2.   

Abstract

Mesh：

Year:  2018        PMID： 29417161     DOI： 10.1007/s00192-018-3553-2

Source DB:  PubMed          Journal:  Int Urogynecol J        ISSN： 0937-3462            Impact factor:   2.894


× No keyword cloud information.
  5 in total

Review 1.  Hysteropreservation versus hysterectomy in the surgical treatment of uterine prolapse: systematic review and meta-analysis.

Authors:  Sofia Andrade de Oliveira; Marcelo C M Fonseca; Maria A T Bortolini; Manoel J B C Girão; Matheus T Roque; Rodrigo A Castro
Journal:  Int Urogynecol J       Date:  2017-08-05       Impact factor: 2.894

2.  Hysteropreservation versus hysterectomy in the surgical treatment of uterine prolapse: systematic review and meta-analyses.

Authors:  Sofia Andrade de Oliveira; Maria A T Bortolini; Rodrigo A Castro
Journal:  Int Urogynecol J       Date:  2017-10-07       Impact factor: 2.894

3.  Comment on "Hysteropreservation versus hysterectomy in the surgical treatment of uterine prolapse: systematic review and meta-analysis".

Authors:  Shveta Kapoor; Kanapathippillai Sivanesan; Vishal Kapoor; Mayooran Veerasingham
Journal:  Int Urogynecol J       Date:  2017-09-18       Impact factor: 2.894

4.  Sacrospinous hysteropexy versus vaginal hysterectomy with suspension of the uterosacral ligaments in women with uterine prolapse stage 2 or higher: multicentre randomised non-inferiority trial.

Authors:  Renée J Detollenaere; Jan den Boon; Jelle Stekelenburg; Joanna IntHout; Mark E Vierhout; Kirsten B Kluivers; Hugo W F van Eijndhoven
Journal:  BMJ       Date:  2015-07-23

5.  One-year follow-up after sacrospinous hysteropexy and vaginal hysterectomy for uterine descent: a randomized study.

Authors:  Viviane Dietz; Carl H van der Vaart; Yolanda van der Graaf; Peter Heintz; Steven E Schraffordt Koops
Journal:  Int Urogynecol J       Date:  2009-10-16       Impact factor: 2.894
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.